Evidence map›Paper›PMID 24670428›Full record

Observational studyBMJ open2014

Feasibility of aerosol drug delivery to sleeping infants: a prospective observational study.

Israel Amirav, Michael T Newhouse, Anthony Luder, Asaf Halamish, Hamza Omar, Miguel Gorenberg

Registry-linked trialOpen access · goldAbstract readEvaluation StudyObservational Study
In one paragraph

Observational study in BMJ open, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01120938 (Do Pacifiers Protect From Sudden Infant Death Syndrome), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01120938 unknown statusnot on this map

Do Pacifiers Protect From Sudden Infant Death Syndrome (SIDS) Through an Increase in Upper Airway Patency?

TypeobservationalSponsorZiv HospitalRan2010 to 2012Enrolled30ConditionsSudden Infant Death
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Israel AmiravPediatric Department, Ziv Medical Center, Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Michael T Newhouse
Anthony Luder
Asaf Halamish
Hamza Omar
Miguel Gorenberg
Bar-Ilan University · ILSt. Joseph's Hospital · CARebecca Sieff Hospital · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesDelivery of inhaled medications to infants is usually very demanding and is often associated with crying and mask rejection. It has been suggested that aerosol administration during sleep may be an attractive alternative. Previous studies in sleeping children were disappointing as most of the children awoke and rejected the treatment. The SootherMask (SM) is a new, gentle and innovative approach for delivering inhaled medication to infants and toddlers. The present pilot study describes the feasibility of administering inhaled medications during sleep using the SM.

designProspective observational study.

settingOut patients.

participants13 sleeping infants with recurrent wheezing who regularly used pacifiers and were <12 months old.

interventionParticipants inhaled technetium99mDTPA-labelled normal saline aerosol delivered via a Respimat Soft Mist Inhaler (SMI) (Boehringer-Ingelheim, Germany) and SM + InspiraChamber (IC; InspiRx Inc, New Jersey, USA). OUTCOMES: The two major outcomes were the acceptability of the treatment and the lung deposition (per cent of emitted dose).

resultsAll infants who fulfilled the inclusion criteria successfully received the SM treatment during sleep without difficulty. Mean lung deposition (±SD) averaged 1.6±0.5% in the right lung.

conclusionsThis study demonstrated that the combination of Respimat, IC and SM was able to administer aerosol therapy to all the sleeping infants who were regular pacifier users with good lung deposition. Administration of aerosols during sleep is advantageous since all the sleeping children accepted the mask and ensuing aerosol therapy under these conditions, in contrast to previous studies in which there was frequent mask rejection using currently available devices. CLINICAL TRIAL REGISTRY: NCT01120938.

Indexed as

AerosolsEquipment DesignLungSleepAdministration, InhalationAsthmaDrug Delivery SystemsFemaleGermanyHumansInfantMaleMasksNebulizers and VaporizersPilot ProjectsProspective StudiesAerosols

Identifiers

PMID24670428
PMCPMC3975762
OpenAlexW2163359229

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.